Curocell (XKRX:372320) Accounts Payable & Accrued Expense : ₩1,380.47 Mil (As of Jun. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Curocell Accounts Payable & Accrued Expense?

Curocell's quarterly accounts payable & accrued expense increased from Jun. 2022 (₩0.00 Mil) to Dec. 2022 (₩4,398.89 Mil) but then declined from Dec. 2022 (₩4,398.89 Mil) to Jun. 2023 (₩1,380.47 Mil).

Curocell's annual accounts payable & accrued expense increased from Dec. 2021 (₩875.54 Mil) to Dec. 2022 (₩4,398.89 Mil) but then declined from Dec. 2022 (₩4,398.89 Mil) to Dec. 2023 (₩1,634.23 Mil).

Curocell Accounts Payable & Accrued Expense Historical Data

The historical data trend for Curocell's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curocell Accounts Payable & Accrued Expense Chart

Curocell Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

239.97

396.51

875.54

4,398.89

1,634.23

Curocell Semi-Annual Data
	Jun22	Dec22	Jun23	Dec23
Accounts Payable & Accrued Expense	-	4,398.89	1,380.47	1,634.23

Curocell Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Curocell (XKRX:372320) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curocell Inc (XKRX:372320) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

11, Gukjegwahak 16-ro, Yuseong-gu, Daejeon, KOR, 34002

Website

https://www.curocellbtx.com

Curocell Inc is engaged in medical and pharmaceutical research and development. The company is into development of CAR-T treatments that enhance the natural function of immune cells to eliminate cancer cells through genetic manipulation of human immune cells.

Curocell (XKRX:372320) Headlines

No Headlines